Fulcrum Therapeutics (FULC)
NASDAQ:FULC
Want to see FULC full AI Analyst Report?
Fulcrum Therapeutics (FULC) Ownership Overview
10.23% Insiders
8.15% Mutual Funds
58.96% Other Institutional Investors
11.58% ETFs
11.09% Public Companies and
Individual Investors
The ownership structure of Fulcrum Therapeutics (FULC) stock is a mix of institutional, retail, and individual investors. Approximately 78.68% of the company’s stock is owned by Institutional Investors, 10.23% is owned by Insiders, and 11.09% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 10, 2025 | xxxxxxxxxxxxx | $58377021 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $327823 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $347052 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,053,960 | Institution | 9.09% | 41,893,403 | |
| 6,053,960 | Insider | 9.09% | 41,893,403 | |
| 3,177,388 | Institution | 4.77% | 21,987,525 | |
| 2,710,345 | Institution | 4.07% | 18,755,587 | |
| 2,623,099 | Institution | 3.94% | 18,151,845 | |
| 619,986 | Institution | 0.93% | 4,290,303 | |
| 546,953 | Institution | 0.82% | 3,784,915 | |
| 506,347 | Institution | 0.76% | 3,503,921 | |
| 487,018 | Institution | 0.73% | 3,370,165 | |
| 454,864 | Insider | 0.68% | 3,147,659 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,623,099 | Institution | 3.94% | 18,151,845 | |
| 619,986 | Institution | 0.93% | 4,290,303 | |
| 546,953 | Institution | 0.82% | 3,784,915 | |
| 487,018 | Institution | 0.73% | 3,370,165 | |
| 248,886 | Institution | 0.37% | 1,722,291 | |
| 167,215 | Institution | 0.25% | 1,157,128 | |
| 128,111 | Institution | 0.19% | 886,528 | |
| 113,751 | Institution | 0.17% | 787,157 | |
| 111,403 | Institution | 0.17% | 770,909 | |
| 53,570 | Institution | 0.08% | 370,704 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,074,332 | Institution | 3.11% | 15,910,126 | |
| 1,401,643 | Institution | 2.10% | 9,755,435 | |
| 549,107 | Institution | 0.82% | 4,211,651 | |
| 465,266 | Institution | 0.70% | 3,238,251 | |
| 418,888 | Institution | 0.63% | 2,915,460 | |
| 408,099 | Institution | 0.61% | 2,856,693 | |
| 294,282 | Institution | 0.44% | 2,257,143 | |
| 232,137 | Institution | 0.35% | 1,624,959 | |
| 219,460 | Institution | 0.33% | 1,536,220 | |
| 188,653 | Institution | 0.28% | 1,580,912 |
FAQ
Who Owns Fulcrum Therapeutics (FULC)?
According to the latest TipRanks data, approximately 58.96% of the company's stock is held by institutional investors, 10.23% is held by insiders, and 11.09% is held by retail investors.
What percentage of Fulcrum Therapeutics (FULC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 58.96% of Fulcrum Therapeutics (FULC) stock is held by institutional investors.
What percentage of Fulcrum Therapeutics (FULC) stock is held by retail investors?
According to the latest TipRanks data, approximately 11.09% of Fulcrum Therapeutics (FULC) stock is held by retail investors.
Who owns the most shares of Fulcrum Therapeutics (FULC)?
Peter Kolchinsky owns the most shares of Fulcrum Therapeutics (FULC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.